Hospitalist Doctors in Hiram, GA Accepting Medicare

4 Hospitalist doctors found. Showing 1 - 4

Aidenojie Eromosele Ihenyen, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2518 Jimmy Lee Smith Pkwy, Hiram, GA 30141 Phone: 770-732-4022    Fax: 770-732-4023

Adanna Ngozi Nwachukwu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2518 Jimmy Lee Smith Pkwy, Hiram, GA 30141 Phone: 770-732-4022    Fax: 770-732-4023

Rasik Parmar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2518 Jimmy Lee Smith Pkwy, Hiram, GA 30141 Phone: 770-732-4022

Iwayemi Olatunde Olayeye, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2518 Jimmy Lee Smith Pkwy, Hiram, GA 30141 Phone: 470-644-7000    Fax: 470-644-8027

News Archive

Study identifies 29 potential DS biomarker proteins in maternal serum

Prenatal screening for Down syndrome (DS) is still in need of improvement. Perinatal medicine experts have worked hard to find new biomarkers for screening of DS. Dr. Shi he Shao and his co-investigators, from Jiangsu University and Changzhou Woman and Children Health Hospital, report in the May 2012 issue of Experimental Biology and Medicine that they have successfully identified twenty-nine differentially expressed proteins in maternal serum from pregnancies carrying DS fetuses with proteomic approaches.

FDA grants approval for first breast cancer drug through 'Real-Time Oncology Review'

The U.S. Food and Drug Administration today approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy.

Elcelyx Therapeutics' posters related to NewMet to be presented at ADA's 73rd Scientific Sessions

Elcelyx Therapeutics today announced that the company and principal investigator Ralph A. DeFronzo, M.D. will present posters related to NewMet, a delayed-release formulation of generic metformin, at the 73rd Scientific Sessions of the American Diabetes Association in Chicago, IL.

Findings show promising evidence for creating broad-spectrum antiviral

UW researchers working in collaboration with Kineta Inc. and the University of Texas at Galveston have shown that making a drug-like molecule to turn on innate immunity can induce genes to control infection in several -known viruses.

Read more Medical News

› Verified 9 days ago